Introduction

Success Story: Customizing NextGENe Software for Forensic Applications

Success Story: Customizing NextGENe Software for Forensic Applications

National Institute of Justice and CHORI - Collaboration with SoftGenetics® and California Department of Justice

Date

April 2016

Overview

Degraded and mixed DNA samples are often encountered in forensic cases and pose interpretation challenges. Mitochondrial DNA (mtDNA) markers are ideal targets for analyzing these samples, as the high copy number of mtDNA and the large number of nucleotide polymorphisms can allow for discrimination among samples. A software program that could analyze the aspects of mtDNA significant to forensics could enable more accurate and rapid DNA analysis.

Dr. Cassandra Calloway of Children’s Hospital Oakland Research Institute (CHORI) recognized that NextGENe software, from SoftGenetics, offered a user-friendly, versatile program that could handle analysis of data generated by many different Massively Parallel Sequencing (MPS) platforms. Dr. Calloway led the research effort with SoftGenetics® to modify NextGENe®, commercial software tool to improve analysis of mtDNA in a forensic context.

"Mitochondrial analysis holds significant potential for the forensic community and represents a great market opportunity for SoftGenetics®. As part of Dr. Calloway’s NIJ funding, we were able to initiate a collaboration to customize the NextGENe® software for forensic use."

- John Fosnacht | Co-Founder/VP Sales & Marketing, SoftGenetics®


Funding for this Forensic Technology Center of Excellence success story was provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this success story are those of the author(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

test tubes and scientists

Things Are Not What They Seem: A Collection of Interesting Case Studies from the Medical Examiner Scene Queens

← Back to Unseen Threats Webinar Series This webinar originally occurred on Thursday, May 19, 2022 Duration: 1 hour Overview With the rise of illicit fentanyl, fentanyl analogues, synthetic cathinones, xylazine, and other substances adulterating many traditional street drugs, users often…
pills and IV

Unseen Threats: A Webinar Series from the AAFS Opioids and Emerging Drugs Ad-Hoc Committee

Overview This webinar series is based on the one-day workshop (“Unseen Threats”) that was sponsored by the Opioids and Emerging Drugs Ad-Hoc Committee at the 2022 American Academy of Forensic Sciences (AAFS) Annual Meeting. To follow up on this workshop,…
woman sad

Strangulation in Sexual Assault Cases: Considerations for Evidence Collection and Supporting Healing

← Back to 2022 Sexual Assault Awareness Month Webinar Series This webinar originally occurred on April 14, 2022 Duration: 1 hour Overview In addition to providing medical care and support to victims of sexual assault, Sexual Assault Nurse Examiners (SANEs)…